Please login to the form below

Not currently logged in
Email:
Password:

Rienso

This page shows the latest Rienso news and features for those working in and with pharma, biotech and healthcare.

Amag buys into maternal health business

Amag buys into maternal health business

Feraheme is sold outside the US by Takeda as Rienso and was approved in Europe in 2012.

Latest news

  • Death leads to recall of batch of Takeda's Rienso in Switzerland Death leads to recall of batch of Takeda's Rienso in Switzerland

    Both Amag and Takeda are now investigating the Swiss batch of Rienso, while the introduction of new batches will depend on approval by Swiss health regulator Swissmedic. ... Rienso is sold as Feraheme in the US and Canada, where Takeda is the exclusive

  • SMC approves Eliquis, restricts use of Rienso SMC approves Eliquis, restricts use of Rienso

    The Scottish Medicines Consortium (SMC) has accepted Eliquis, Pfizer and Bristol-Myers Squibb's anticoagulant, and backed the restricted use of Takeda's anaemia drug Rienso within NHS Scotland. ... it. “Acceptance of Rienso by the SMC marks an

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....